Justin Chakma, Chief Officer of ARS Pharmaceuticals SPRY, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $1.5M. The latest trade was on 01/02.

JC

JC

Justin Chakma

Chief Business Officer

Company

ARS Pharmaceuticals SPRY

First filing

23/01/05

Trades

37 trades

Buys / sales

0 / 13

12-month net buying

−$1.5M

Last trade

01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ARS PharmaceuticalsSPRY	Open-market sale	25/11/12	25/11/14	166,380 sh2 trades	$8.87avg.	$1,475,626.8	−100.0%
ARS PharmaceuticalsSPRY	Open-market sale	24/12/12–24/12/13	24/12/13	144,605 sh2 trades	$12.23avg.	$1,768,576.23	−51.5%
ARS PharmaceuticalsSPRY	Open-market sale	24/12/10	24/12/12	50,000 sh	$13.15	$657,500	−26.8%
ARS PharmaceuticalsSPRY	Open-market sale	24/12/04–24/12/06	24/12/06	144,640 sh3 trades	$14.11avg.	$2,040,663.2	−51.5%
ARS PharmaceuticalsSPRY	Open-market sale	24/12/02–24/12/03	24/12/04	90,000 sh2 trades	$13.43avg.	$1,208,700	−39.8%
ARS PharmaceuticalsSPRY	Open-market sale	24/11/25–24/11/27	24/11/27	100,000 sh3 trades	$14.12avg.	$1,411,859.3	−42.3%